Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus Aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects
NCT02940626 is registered in ClinicalTrials.gov with Arsanis, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus Aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects
- Lead sponsor
- Arsanis, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2016
- Completion date
- September 28, 2018
- Enrollment
- 155 (actual)
- Sites
- 93
Conditions
As the registry lists them; a condition with its own page is linked.